Impact of policy changes and drug shortages on acamprosate and naltrexone use in Ontario, Canada
Konstantelos N, Tourchian N, McCormack D, Lecce P, Tadrous M, Gomes T. Drug Alcohol Depend. 2023; 242:109705. Epub 2022 Nov 19.
Publications
Impact of antegrade enema initiation on healthcare utilization in pediatric patients: a population-based cohort study
Gould MJ, Marcon MA, Nguyen GC, Benchimol EI, Moineddin R, Swayze S, Kopp A, Ratcliffe EM, Merritt N, Davidson J, Langer JC, Mistry N, Lorenzo AJ, Temple M, ine M Walsh CM. Neurogastroenterol Motil. 2023; 35(3):e14495. Epub 2022 Nov 15.
Mediating effect of vascular risk factors underlying the link between gestational diabetes and cardiovascular disease
Retnakaran R, Shah BR. BMC Med. 2022; 20(1):389. Epub 2022 Nov 4.
The association between offspring birthweight and future risk of maternal diabetes: a population-based study
Nham T, Read SH, Giannakeas V, Berger H, Feig DS, Fleming K, Ray JG, Rosella L, Shah BR, Lipscombe LL. Diabet Med. 2023; 40(2):e14991. Epub 2022 Oct 25.
Risk of SARS-CoV-2 infection following initial COVID-19 vaccination: population-based cohort study
Tadrous M, Chung H, Men S, Chu C, Campbell T, Juurlink DN, Kwong JC, Paterson JM, Gomes T. PLoS One. 2022; 17(10):e0273903. Epub 2022 Oct 20.
Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: a cross-sectional time-series analysis
Chang A, Chaudhry S, McCormack D, Gomes T, Shivji A, Tadrous M. Can Pharm J (Ott). 2022; Oct 12 [Epub ahead of print].
Trimethoprim-sulfamethoxazole and the risk of a hospital encounter with hyperkalemia: a matched population-based cohort study
Hwang YJ, Muanda FT, McArthur E, Weir MA, Sontrop JM, Lam NN, Garg AX. Nephrol Dial Transplant. 2023; 38(6):1459-68. Epub 2022 Oct 7.
Does early life exposure to exogenous sources of reactive oxygen species (ROS) increase the risk of respiratory and allergic diseases in children? A longitudinal cohort study
To T, Terebessy E, Zhu J, Zhang K, Lakey PS, Shiraiwa M, Hatzopoulou M, Minet L, Weichenthal S, Dell S, Stieb D. Environ Health. 2022; 21(1):90. Epub 2022 Oct 3.
Changes in service delivery and access to rheumatologists before and during the COVID-19 pandemic in a Canadian universal healthcare setting
Kwok TSH, Kuriya B, King LK, Eder L, Thorne C, Li Z, Stukel T, Fu L, Kopp A, Widdifield J. J Rheumatol. 2022; Oct 1 [Epub ahead of print].
Prescribing characteristics associated with opioid overdose following buprenorphine taper
Bozinoff N, Men S, Kurdyak P, Selby P, Gomes T. JAMA Netw Open. 2022; 5(9):e2234168. Epub 2022 Sep 29.